Doximity Names Interim CFO and Announces New Buyback

Doximity ( (DOCS) ) has provided an update.

On February 5, 2026, Doximity announced that Chief Financial Officer and principal accounting officer Anna Bryson had taken a temporary medical leave of absence, effective earlier that week, and that Chief Accounting Officer Siddharth Sitaram, a long-serving finance executive at the company, had been appointed interim principal financial and accounting officer. The company also reported fiscal third-quarter 2026 results for the period ended December 31, 2025, highlighted by a 10% year-over-year revenue increase to $185.1 million, adjusted EBITDA of $111.4 million with a 60% margin, and strong user engagement across its newsfeed, workflow, and emerging AI products, even as net income and operating cash flow declined versus the prior year. In tandem with its results, Doximity issued updated guidance for its fiscal fourth quarter and full year and unveiled a new stock repurchase authorization of up to $500 million, signaling continued confidence in its balance sheet strength and long-term growth prospects while returning capital to shareholders.

The most recent analyst rating on (DOCS) stock is a Hold with a $45.00 price target. To see the full list of analyst forecasts on Doximity stock, see the DOCS Stock Forecast page.

Spark’s Take on DOCS Stock

According to Spark, TipRanks’ AI Analyst, DOCS is a Outperform.

The score is driven primarily by strong financial fundamentals (high margins, strong cash conversion, low leverage) and a constructive earnings update with revenue/EBITDA beats and raised outlook. Offsetting these positives, technical signals are notably weak (below major moving averages with negative MACD), and valuation remains demanding at a ~35.6 P/E. The proposed insurance-funded litigation settlement is a modest additional positive.

To see Spark’s full report on DOCS stock, click here.

More about Doximity

Founded in 2010, Doximity is a healthcare-technology company that operates the leading digital platform for U.S. medical professionals, counting more than 85% of U.S. physicians as members across specialties. The company offers a suite of digital tools that enable clinicians to collaborate, keep up with medical news and research, manage careers and on-call schedules, streamline documentation and administrative tasks, conduct virtual patient visits, and access AI-powered clinical reference and search capabilities, with a mission to help doctors be more productive and improve patient care.

Average Trading Volume: 2,849,081

Technical Sentiment Signal: Sell

Current Market Cap: $6.64B

For an in-depth examination of DOCS stock, go to TipRanks’ Overview page.